Primary Site >> Biliary tract Cancer

Gene >> BRCA2

  • 1999
  • 2001
  • 2006
  • 2014
  • 2016
  • 2017
  • 2018
Ref: Cancer risks in BRCA2 mutation carriers.
PMID: 10433620
 Ref: The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
PMID: 11207041
 Ref: Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report.
PMID: 16982466
 Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
PMID: 24563076
 Ref: Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
PMID: 26500333
Ref: Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.
PMID: 27532258
Ref: Response of BRCA1-mutated gallbladder cancer to olaparib: A case report.
PMID: 28028375
 Ref: Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
PMID: 28487467
 Ref: Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
PMID: 29360550
Ref: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
PMID: 29416916
Ref: Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report.
PMID: 30271179